CT-DERIVED BODY COMPOSITION AND MACHINE LEARNING FOR PROGNOSTIC IMPROVEMENT IN COLORECTAL CANCER

IF 1.5 Q3 HEMATOLOGY
Hematology, Transfusion and Cell Therapy Pub Date : 2026-03-01 Epub Date: 2026-03-05 DOI:10.1016/j.htct.2026.106275
Pedro Henrique Alves, Vinicius Barbosa Bassete, Jun Takahashi, Maria Carolina Santos Mendes, José Barreto Campello Carvalheira
{"title":"CT-DERIVED BODY COMPOSITION AND MACHINE LEARNING FOR PROGNOSTIC IMPROVEMENT IN COLORECTAL CANCER","authors":"Pedro Henrique Alves,&nbsp;Vinicius Barbosa Bassete,&nbsp;Jun Takahashi,&nbsp;Maria Carolina Santos Mendes,&nbsp;José Barreto Campello Carvalheira","doi":"10.1016/j.htct.2026.106275","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Translational research in cancer theranostics aims to transform routinely acquired clinical and imaging data into robust and clinically actionable biomarkers. In colorectal cancer (CRC), computed tomography (CT) is widely used for staging and follow-up and represents a valuable source of quantitative body composition biomarkers. However, the integration of high-dimensional radiomics into predictive models faces challenges related to performance, interpretability, and feature stability.</div></div><div><h3>Objectives</h3><div>To evaluate the prognostic performance and stability of machine learning (ML) models for overall survival prediction in colorectal cancer using clinical data and CT-derived body composition features.</div></div><div><h3>Materials and methods</h3><div>A retrospective cohort of 1553 CRC patients was analyzed; 915 met data quality criteria and were included in the primary analysis, in which ML models were trained using 31 clinical and laboratory variables. A CT-imaging subset (n = 448) was subsequently evaluated to assess model robustness and to incorporate 39 body composition radiomics features derived from skeletal muscle, visceral adipose tissue, and subcutaneous adipose tissue. To address high dimensionality, a principal component analysis (PCA)-based reduction pipeline was implemented, with clinically relevant components selected using SHAP feature importance and recursive feature inclusion. At each step, feature ranking stability was quantified using the Jensen-Shannon Divergence (JSD) across 1200 iterations.</div></div><div><h3>Results</h3><div>Using clinical variables alone, logistic regression (LR) achieved an area under the ROC curve (AUC) of 0.86 in the full cohort and 0.84 in the CT subset. Prior to dimensionality reduction in the CT subset, LR slightly outperformed boosted decision trees (BDT) in discriminative power, while BDT exhibited lower feature selection stability (JSD = 0.65) compared to LR (JSD = 0.80). The inclusion of body composition features did not improve AUC; however, radiomics variables such as skeletal muscle predicted area, skeletal muscle median radiodensity, and visceral adipose tissue 90th percentile consistently ranked among the most relevant predictors. After PCA-based dimensionality reduction, LR maintained its discriminative performance (AUC = 0.84) with a moderate decrease in stability (JSD = 0.71), whereas BDT showed a marked improvement in stability (JSD = 0.81) despite a minor reduction in AUC. These results indicate a clear trade-off between discrimination and robustness, with BDT demonstrating greater gains in stability in lower-dimensional feature spaces.</div></div><div><h3>Conclusion</h3><div>Machine learning models demonstrated consistent performance in predicting overall survival in colorectal cancer using routinely available clinical data. The inclusion of CT-derived body composition features did not improve discriminative performance but revealed a clear trade-off between predictive accuracy and feature stability. Dimensionality reduction through PCA preserves model performance and may play an important role in improving model interpretability and stability, which are essential for the translational application of theranostic models.</div></div>","PeriodicalId":12958,"journal":{"name":"Hematology, Transfusion and Cell Therapy","volume":"48 ","pages":"Article 106275"},"PeriodicalIF":1.5000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology, Transfusion and Cell Therapy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2531137926000222","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/5 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Translational research in cancer theranostics aims to transform routinely acquired clinical and imaging data into robust and clinically actionable biomarkers. In colorectal cancer (CRC), computed tomography (CT) is widely used for staging and follow-up and represents a valuable source of quantitative body composition biomarkers. However, the integration of high-dimensional radiomics into predictive models faces challenges related to performance, interpretability, and feature stability.

Objectives

To evaluate the prognostic performance and stability of machine learning (ML) models for overall survival prediction in colorectal cancer using clinical data and CT-derived body composition features.

Materials and methods

A retrospective cohort of 1553 CRC patients was analyzed; 915 met data quality criteria and were included in the primary analysis, in which ML models were trained using 31 clinical and laboratory variables. A CT-imaging subset (n = 448) was subsequently evaluated to assess model robustness and to incorporate 39 body composition radiomics features derived from skeletal muscle, visceral adipose tissue, and subcutaneous adipose tissue. To address high dimensionality, a principal component analysis (PCA)-based reduction pipeline was implemented, with clinically relevant components selected using SHAP feature importance and recursive feature inclusion. At each step, feature ranking stability was quantified using the Jensen-Shannon Divergence (JSD) across 1200 iterations.

Results

Using clinical variables alone, logistic regression (LR) achieved an area under the ROC curve (AUC) of 0.86 in the full cohort and 0.84 in the CT subset. Prior to dimensionality reduction in the CT subset, LR slightly outperformed boosted decision trees (BDT) in discriminative power, while BDT exhibited lower feature selection stability (JSD = 0.65) compared to LR (JSD = 0.80). The inclusion of body composition features did not improve AUC; however, radiomics variables such as skeletal muscle predicted area, skeletal muscle median radiodensity, and visceral adipose tissue 90th percentile consistently ranked among the most relevant predictors. After PCA-based dimensionality reduction, LR maintained its discriminative performance (AUC = 0.84) with a moderate decrease in stability (JSD = 0.71), whereas BDT showed a marked improvement in stability (JSD = 0.81) despite a minor reduction in AUC. These results indicate a clear trade-off between discrimination and robustness, with BDT demonstrating greater gains in stability in lower-dimensional feature spaces.

Conclusion

Machine learning models demonstrated consistent performance in predicting overall survival in colorectal cancer using routinely available clinical data. The inclusion of CT-derived body composition features did not improve discriminative performance but revealed a clear trade-off between predictive accuracy and feature stability. Dimensionality reduction through PCA preserves model performance and may play an important role in improving model interpretability and stability, which are essential for the translational application of theranostic models.
ct衍生体成分和机器学习用于改善结直肠癌的预后
癌症治疗学的转化研究旨在将常规获得的临床和成像数据转化为可靠的临床可操作的生物标志物。在结直肠癌(CRC)中,计算机断层扫描(CT)广泛用于分期和随访,是定量体成分生物标志物的宝贵来源。然而,将高维放射组学集成到预测模型中面临着与性能、可解释性和特征稳定性相关的挑战。目的利用临床数据和ct衍生的身体成分特征,评估机器学习(ML)模型预测结直肠癌总生存期的预后性能和稳定性。材料与方法对1553例结直肠癌患者进行回顾性队列分析;915例符合数据质量标准,纳入初步分析,其中ML模型使用31个临床和实验室变量进行训练。随后对ct成像子集(n = 448)进行评估,以评估模型的稳健性,并纳入来自骨骼肌、内脏脂肪组织和皮下脂肪组织的39个身体组成放射组学特征。为了解决高维问题,实现了基于主成分分析(PCA)的约简管道,使用SHAP特征重要性和递归特征包含选择临床相关成分。在每个步骤中,使用跨1200次迭代的Jensen-Shannon散度(JSD)对特征排序稳定性进行量化。结果仅使用临床变量,logistic回归(LR)在全队列中的ROC曲线下面积(AUC)为0.86,在CT子集中的AUC为0.84。在CT子集降维之前,LR在判别能力上略优于增强决策树(BDT),而BDT的特征选择稳定性(JSD = 0.65)低于LR (JSD = 0.80)。纳入体成分特征并没有改善AUC;然而,放射组学变量,如骨骼肌预测面积、骨骼肌中位放射密度和内脏脂肪组织第90百分位始终被列为最相关的预测因子。基于pca的降维后,LR保持了其判别性能(AUC = 0.84),但稳定性略有下降(JSD = 0.71),而BDT尽管AUC略有下降,但稳定性却有显著改善(JSD = 0.81)。这些结果表明了识别和鲁棒性之间的明显权衡,BDT在低维特征空间中表现出更大的稳定性。结论:利用常规临床数据,机器学习模型在预测结直肠癌患者总生存率方面表现一致。包含ct衍生的身体成分特征并没有提高判别性能,但显示了预测准确性和特征稳定性之间的明确权衡。通过PCA降维可以保持模型的性能,并在提高模型的可解释性和稳定性方面发挥重要作用,这对于治疗模型的转化应用至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.40
自引率
4.80%
发文量
1419
审稿时长
30 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书